Reference:
1. Richman DD WR, Hayden FG. Clinical virology . 4th ed.
Washington: ASM Press, 2016.
2. Drosten C, Gunther S, Preiser W, et al. Identification of a novel
coronavirus in patients with severe acute respiratory syndrome. N Engl J
Med 2003;348 (20):1967-76 doi: 10.1056/NEJMoa030747[published
Online First: Epub Date]|.
3. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus
associated with severe acute respiratory syndrome. N Engl J Med
2003;348 (20):1953-66 doi: 10.1056/NEJMoa030781[published
Online First: Epub Date]|.
4. Kuiken T, Fouchier RA, Schutten M, et al. Newly discovered
coronavirus as the primary cause of severe acute respiratory syndrome.
Lancet 2003;362 (9380):263-70 doi:
10.1016/S0140-6736(03)13967-0[published Online First: Epub
Date]|.
5. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA.
Isolation of a novel coronavirus from a man with pneumonia in Saudi
Arabia. N Engl J Med 2012;367 (19):1814-20 doi:
10.1056/NEJMoa1211721[published Online First: Epub Date]|.
6. de Groot RJ, Baker SC, Baric RS, et al. Middle East respiratory
syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study
Group. J Virol 2013;87 (14):7790-2 doi:
10.1128/JVI.01244-13[published Online First: Epub Date]|.
7. 高艳梅, 魏芳.
细胞凋亡抑制蛋白-1在宫颈癌及宫颈癌化疗耐药方面的研究进展.
中华临床医师杂志(电子版) (4)
8. PD M, S S, CL D. Assembling the building blocks: structure and
function of inhibitor of apoptosis proteins. Cell death and
differentiation 2010;17 (1):46-53 doi:
10.1038/cdd.2009.45[published Online First: Epub Date]|.
9. Lacasse EC, Baird S, Korneluk RG, MacKenzie AE. The inhibitors of
apoptosis (IAPs) and their emerging role in
cancer.17 (25):3247-59
10. Deveraux QL, Takahashi R, Salvesen GS, Reed JC. X-Linked IAP is a
direct inhibitor of cell-death proteases. Nature
1997;388 (6639):300-04
11. Chai J, Du C, Wu JW, Kyin S, Shi Y. Structural and biochemical basis
of apoptotic activation by Smac/DIABLO. Nature
2000;406 (6798):855-62
12. Yu W-BT, Guang-Da ;Zhang, Li ; Corlett, Richard T. . Decoding the
evolution and transmissions of the novel pneumonia coronavirus
(SARS-CoV-2) using whole genomic data.
13. Coronavirus disease (COVID-19) Situation dashboard: WHO., 2020.
14. China NHCotPsRo. Diagnosis and treatment of pneumonia caused by
novel coronavirus infection (Trial version 5), 2020.
15. China NHCotPsRo. Diagnosis and treatment of severe and critical
cases of new coronavirus pneumonia (Trial version 2), 2020.
16. Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia
associated with the 2019 novel coronavirus indicating person-to-person
transmission: a study of a family cluster. Lancet
2020;395 (10223):514-23 doi:
10.1016/S0140-6736(20)30154-9[published Online First: Epub
Date]|.
17. Notice of leading group for prevention and control of pneumonia
caused by new coronavirus infection in wenzhou city (No.1). In: city
Lgfpacopcbnciiw, ed. Wenzhou: Wenzhou daily nespaper, 2020.
18. Notice of leading group for prevention and control of pneumonia
caused by new coronavirus infection in wenzhou city (No.6). In: city
Lgfpacopcbnciiw, ed. Wenzhou: Wenzhou daily nespaper, 2020.
19. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138
Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in
Wuhan, China. JAMA 2020 doi: 10.1001/jama.2020.1585[published Online
First: Epub Date]|.
20. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical
characteristics of 99 cases of 2019 novel coronavirus pneumonia in
Wuhan, China: a descriptive study. Lancet
2020;395 (10223):507-13 doi:
10.1016/S0140-6736(20)30211-7[published Online First: Epub
Date]|.
21. Ki M, nCo VT. Epidemiologic characteristics of early cases with 2019
novel coronavirus (2019-nCoV) disease in Republic of Korea. Epidemiol
Health 2020:e2020007 doi: 10.4178/epih.e2020007[published Online
First: Epub Date]|.
22. Wang D, Ju XL, Xie F, et al. [Clinical analysis of 31 cases of
2019 novel coronavirus infection in children from six provinces
(autonomous region) of northern China]. Zhonghua Er Ke Za Zhi
2020;58 (4):E011 doi:
10.3760/cma.j.cn112140-20200225-00138[published Online First: Epub
Date]|.
23. Xie C, Jiang L, Huang G, et al. Comparison of different samples for
2019 novel coronavirus detection by nucleic acid amplification tests.
Int J Infect Dis 2020 doi: 10.1016/j.ijid.2020.02.050[published Online
First: Epub Date]|.
24. Xu K, Cai H, Shen Y, et al. [Management of corona virus disease-19
(COVID-19): the Zhejiang experience]. Zhejiang Da Xue Xue Bao Yi Xue
Ban 2020;49 (1):0
25. To KK, Tsang OT, Chik-Yan Yip C, et al. Consistent detection of 2019
novel coronavirus in saliva. Clin Infect Dis 2020 doi:
10.1093/cid/ciaa149[published Online First: Epub Date]|.
26. Yang W, Cao Q, Qin L, et al. Clinical characteristics and imaging
manifestations of the 2019 novel coronavirus disease (COVID-19):A
multi-center study in Wenzhou city, Zhejiang, China. J Infect 2020 doi:
10.1016/j.jinf.2020.02.016[published Online First: Epub
Date]|.
27. Xu YH, Dong JH, An WM, et al. Clinical and computed tomographic
imaging features of Novel Coronavirus Pneumonia caused by SARS-CoV-2. J
Infect 2020 doi: 10.1016/j.jinf.2020.02.017[published Online First:
Epub Date]|.
28. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated
with a new coronavirus of probable bat origin. Nature 2020 doi:
10.1038/s41586-020-2012-7[published Online First: Epub
Date]|.
29. mRNA Expression by UniProt/SwissProt for ACE2 Gene: GeneCards, 2020.